Applications published 15 November 2006
Lyophilisation method to improve excipient crystallisation
Wyeth 1720519*
Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof
Nod Pharmaceuticals 1720520*
Improved efficacy and safety of targeted particulate agents with decoy systems
Barnes-Jewish Hospital 1720521*
Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination and administration of gene based drugs
Salvona 1720522*
Cyclosporin formulations
Teva Pharmaceuticals 1720523*
Extended release tablets of clarithromycin
Ranbaxy Laboratories 1720524*
Powdered compsns of sensitive active materials in an at least partially amorphous state
Britannia Pharmaceuticals 1720525*
Coated conditioners for use in food and pharmaceuticals
JM Huber Corp 1720526*
A stable pharmaceutical compsn comprising an acid labile drug
Teva Pharmaceutical Industries 1720527*
Layered sulphate nanoparticle-polymer composite medical articles
Boston Scientific 1720528*
Kit that comprising a plaster that optionally contains an active ingredient and an agent that prevents skin irritation
Gruenenthal 1720529*
Screening method for emulators of neural activity and digestive system using GPR35
Pfizer 1720530*
New compsns containing quinoline compounds
Active Biotech 1720531*
Controlled release formulations
Innovative Drug Delivery Systems 1729532*
Amoxicillin instant granulate
Sandoz 1720533*
Method and compsn for burned skin
Yissum Research Development Company of the Hebrew University of Jerusalem 1720534*
Treating or preventing diabetes with cannabidiol
Yissum Research Development Company of the Hebrew University of Jerusalem; Hadasit Medical Research Services and Development 1720535*
Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome
Borody, Thomas Julius 1720536*
Compsns of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines
Wyeth 1720537*
Method for inducing cell death with carbonyl scavengers
The Arizona Board of Regents on behalf of the University of Arizona 1720538*
Schizochytrium fatty acid synthase (FAS) and products and methods related thereto
Martek Biosciences 1720539*
Methods for treating resistant or refractory tumours
GPC Biotech 1720540*
Treatment of prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites
Sepracor 1720541*
Arylakylamino-substituted quinazoline analogues
Neurogen 1720542*
Roflumilast and glycopryrronium combination
Altana Pharma 1720543*
Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compsns containing same
Les Laboratoires Servier 1720544*
Bicyclic and bridged nitrogen heterocycles
ChemoCentryx 1720545*
Novel, sustained action beta-2-agonists and their use as medicaments
Boehringer Ingelheim International 1720546*
Use of gaboxadol for treating insomnia
H Lundbeck 1720547*
Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents
Wyeth 1720548*
KV1,5-blocker for the selective increase of atrial contractility and treatment of cardiac insufficiency
Sanofi-Aventis Deutschland 1720549*
Derivatives of piperidinylalkyl-carbamates, preparation method thereof and use of same as FAAH enzyme inhibitors
Sanofi-Aventis 1720550*
Alkaloid formulations
Vital Health Sciences 1720551*
Methods for treating inflammatory and autoimmune diseases
Arizona Board of Regents, acting for and on behalf of Arizona State University; Sun Health Research Institute 1720552*
Pyrimidine compounds as purine receptor antagonist
Vernalis (R&D) 1720553*
Use of meloxicam for the treatment of respiratory diseases in pigs
Boehringer Ingelheim Vetmedica 1720554*
Tetracycline derivatives for the treatment of ocular pathologies
Advanced Ocular Systems 1720555*
Novel 2'-C-methyl nucleoside derivatives
Merck 1720556*
Rapidly disintegrating taste-masked tablet
Nutriset; Laboratoires Pharmaceutiques Rodael 1720557*
Compsn and method for use in cartilage affecting conditions
Hill's Pet Nutrition 1720558*
An anti-inflammatory, cytoprotective factor derivable from a probiotic organism
The University of Chicago 1720559*
Compsn of labdane diterpenes extracted from andographis paniculata, useful for the treatment of autoimmune diseases, and Alzheimer's disease by activation of PPR-gamma receptors
Universidad Austral de Chile 1720561*
Botanical extract compsn
Taal-Vlas, Anita Monique; Taal, Leendert 1720562*
Method for treating cardiac remodelling following myocardial injury
Scios 1720563*
Methods and compsns for the treatment of inflammation
Integrated Botanical Technologies 1720563*
Methods of treating obesity or diabetes using NT-4/5
Rinat Neuroscience 1720564*
Co-encapsulated WT1 polypeptide and immunostimulant microsphere formulations and method thereof
Corixa 1720565*
A vaccine comprising an immunoadjuvant compound consisting of a RHO RTPase family activator
INSERM 1720566*
Compsn and method for the treatment of carcinoma
Innate Pharma 1720567*
Immunostimulatory viral RNA oligonucleotides
Coley Pharmaceutical Group 1720568*
Target for B-cell disorders
Pacmab 1720569*
Treatment of dengue haemorrhagic fever
Cangene 1720570*
Method of treating haemolytic disease
Alexion Pharmaceuticals 1720571*
Monovalent ligand of the FCAL-phari receptor as an anti-inflammatory agent
Institut National de la Sante et de la Recherche Medicale 1720572*
Methods and compsns for treating IL-13 related pathologies
Centocor 1720573*
Method of treating abnormal cell growth using C-MET and -TOR inhibitor
Sugen; Dana-Farber Cancer Institute 1720574*
Therapeutic and diagnostic conjugates for use with multispecific antibodies
Immunomedics 1720575*
Photodynamic therapy for the treatment of acne
QLT 1720576*
Ciclesonide and glycopyrronium combination
Altana Pharma 1720577*
Bacteriostatic esters for topical use
Varna Farmacosmetica 1720578*
Galactomannans and/or glucomannans for increasing the bioavailability of active substances
Wheli Inter 1720579*
Improvement in the ligand protection for maceptoacetyl triglycine
Mallinckrodt 1720580*
Alcohol metabolism moderation compsn
Matuschka-Greiffenclau; Markus, Graf von; Jander, Hans Peter 1720610*
Diagnostic marker for cancer
ProteoSys 1720611*
Cancer treatment with topoisomerase-II inhibitor, a bis-dioxypiperazine and radiation
Topotarget 1720612*
Fused tricyclic compounds as inhibitors of 17-beta-hydroxysteroid dehydrogenase 3
Bristol-Myers Squibb 1720613*